BioWorld

Feb. 18, 2003

Neose Secures $17M Privately To Advance Internal Programs

Neose Technologies Inc. is raising $17 million through a private placement of common stock. The Horsham, Pa.-based company said late Thursday it entered into a definitive agreement to sell about 2.9 million common shares for $6 apiece. (BioWorld Today) Read More

GSK's Decision To Limit Sales Rankles Some Representatives

By Walling Off Cyanide, Scientists Seek Pollution-Free Hydrogen Fuel For Industry, Medical Applications

Vertex, GSK Present Preliminary Results From Two Pivotal Trials

Holiday Notice

BioWorld's offices were closed Monday in observance of the Presidents Day holiday in the U.S. No issue was published that day. Read More

Dolly, A Symbol Of Biotech, Dies At 6 From Lung Disease

Other News To Note

Today's news in brief

BioWorld

BioWorld briefs for Jan 9, 2025.

Today's news in brief

BioWorld MedTech

BioWorld MedTech briefs for Jan. 9, 2026.

3D rendering of antibody drug conjugated with cytotoxic payload

ADCs’ breakout 2025 and their still-unfinished potential

BioWorld Science

Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...

Development and characterization of anti-CD19 in vivo CAR T therapy

BioWorld Science

Shenzhen Grit Biotechnology Co. Ltd. and Shanghai Vitalgen Biopharma Co. Ltd. recently presented their work to develop and evaluate a novel anti-CD19 in vivo CAR...

Preclinical results of anti-ADAMTS13 antibody in acquired von Willebrand syndrome

BioWorld Science

The acquired von Willebrand syndrome (AVWS) is a rare bleeding disorder with laboratory findings similar to those of inherited von Willebrand disease. Researchers...